PLC (NASDAQ:SMX) is introducing a new level of transparency and control to the oil and gas industry, enabling real-time authentication and traceability across one of the ...
Castle Biosciences is back in focus as some analysts move price targets from the mid $30s to around $52, while at least one fair value view at $48.5 remains unchanged. These shifts are being tied ...